Agenda

PharmaSupply, GIRP’s flagship conference on the pharmaceutical supply chain, will bring together EU regulators, policymakers, industry leaders, and healthcare stakeholders at its 2026 edition to address the regulatory, operational, and technological changes reshaping Europe’s medicines supply chain.

PharmaSupply 2026 will provide a platform to understand, anticipate, and respond to the regulatory developments, structural challenges, and innovation opportunities facing the pharmaceutical supply chain in Europe.

DAY 1, NOVEMBER 4

WELCOME COFFEE & REGISTRATION 

8:30-9:00

OPENING REMARKS
Katarina Gabrielson, CEO, Oriola & President, GIRP 

9:00-9:05

KEYNOTE The Evolution of the European Regulatory Landscape: The GPL and What It Means for the Supply Chain
Olivér Várhelyi, European Commissioner for Health and Animal Welfare (TBC)  

9:05-9:25

IQVIA PRESENTATION – Supply Chain Review 2026: New Products, New Channels, New Opportunities

  • Simon Tottman, Vice President, Global Strategic Partners, IQVIA
  • Max Newton, Principal, Global Strategic Partners, IQVIA 

9:25-10:00

PANEL  Implementing the General Pharmaceutical Legislation: Perspectives from Across the Supply Chain

  • Agnès Mathieu-Mendes, Head of Unit, DG SANTE, Medical products: Quality, Safety, Innovation, European Commission  
  • Ilaria Passarani, Secretary General, PGEU
  • Mari Krass, CEO, Magnum AS  
  • Hugues Malonne, CEO, Federal Agency for Medicines and Healthcare Products

10:00-11:00

COFFEE BREAK

11:00-11:30

KEYNOTE  The New GDP Guidelines: How Will European Inspection Evolve?
Emil Schwan, Scientific Specialist, European Medicines Agency & Chair of the
GDP Drafting Group 

11:30-11:45

PRESENTATION – Wholesaler’s Position on the New GDP Delegated Regulation
Laura Ribeiro, Head of Quality and Regulatory Affairs, OCP Portugal (TBC)

11:45-12:00

PANEL – The Future of GDP: Inspectors’ View
Moderator: Peter Brown, Expert GDP Inspector, Medicines and Healthcare Products Regulatory Agency 

  • Emil Schwan, Scientific Specialist, European Medicines Agency & Chair of the
    GDP Drafting Group 
  • Manuel Ibarra, Head of Department, Pharmaceutical Inspection and
    Enforcement Department, AEMPS
  • Lisa Byrne, Acting Market Surveillance Manager, Health Products Regulatory Authority (HPRA) 
  • Further inspectors to be announced

12:00-13:00

LUNCH BREAK

13:00-14:00

FIRESIDE CHAT – From Data to Decision: How Digital Transformation Is Reshaping the Pharmaceutical Supply Chain

  • Elizabeth Theophille, Chief Digital Transformation Officer, Sandoz (TBC)
  • Kasper Ernest, Director-General, GIRP 

14:00-14:20

PANEL  The Way Towards Digital Transformation: Enabling Data as Building Blocks

  • Frederic Menardo, Regional Vice President, NNIT  
  • Elizabeth Theophille, Chief Digital Transformation Officer, Sandoz (TBC)
  • Vilma Fairclough, Chairwoman of the Board, Repharm
  • Elina Drakvik, Senior Lead, Future Well-Being Solution, Sitra (TBC)

14:20-15:10

KNAPP PRESENTATION

Dieter Hochörtler, Director Sales & Systems Engineering Europe, KNAPP

15:10-15:25

COFFEE BREAK

15:25-15:55

CASE PRESENTATION – Medication Adherence Packaging
Edith Schippers, CEO, Mosadex

15:55-16:10

PANEL – Medicine Adherence in Europe: Is the Framework Fit for Purpose?

  • Patrick Van Ginneken, Director, Residential Care, Multipharma  
  • Edith Schippers, CEO, Mosadex
  • Mark Roylance, Global Industry Leader – Patient-Specific Medication, BD Rowa 
  • Heidi McVay, Director, Commercial Business Department, PHOENIX Group  

16:10-17:00

CLOSING REMARKS
Kasper Ernest, Director-General, GIRP 

17:00

CONFERENCE DINNER at the Royal Museum of Art & History
Parc du Cinquantenaire, Brussels, Belgium

19:00-22:30

DAY 2, NOVEMBER 5

OPENING KEYNOTE Shortages in Europe: Political Priority and Shared Responsibility
Monica Dias, Head of Supply and Availability of Medicines and Medical Devices, EMA 

9:00-9:25

IQVIA PRESENTATION Shortages Dynamics in Europe
Irena Toneva, Director, Supplier Services, IQVIA 

9:25-9:40

PANEL Shortages: Monitoring, Dialogue and Practice

  • Monica Dias, Head of Supply and Availability of Medicines and Medical Devices, EMA 
  • Momir Radulović, Executive Director, Slovenian Medicines and Medical
    Devices Agency (TBC) 
  • Bénédicte Bertholom, Deputy Director of Inspection, ANSM (TBC) 
  • Katarína Gatialová, Director, EU Government Affairs & Policy, Viatris 
  • Koen Straetmans, CEO Febelco  

9:40-10:40

COFFEE BREAK

10:40-11:10

Car Fibreglass PRESENTATION
Lucas Bardoni, CEO, Car Fibreglass 

11:10-11:25

PANEL Shaping Logistics to Future Needs: What’s New in the Pharmaceutical Supply Chain

  • Thomas De Bie, CEO, CAPPI  
  • Thomas Hunt, Podcast Host, Cold Chain Insight & Managing Director, 
    TLX Cargo Ltd (TBC)
  • Saddam Huq, Director, Cold Chain and Logistics, GSK (TBC) 
  • Katarina Gabrielson, CEO, Oriola & President, GIRP 

11:25-12:25

CLOSING REMARKS
Kasper Ernest, Director-General, GIRP  

12:25